VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 0962069
Sex: F
Age:
State: IA

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies: Darvocet Amlodipine

Symptoms: Headache start about 13:00 on 1/11/21 - Headache worsened through the evening & night. Tylenol no helpful by 1000 on 1/12/21 body aches were starting and worsened extreme fatigue. Slept off & on from 1800 on 1/12/21 until 0600 on 1/13/21 HA was gone body aches much better & gone by 1000.

Other Meds: Atorvastatin, Levothyroxine, Pantoprazole Metoprolol, Meloxicam, ASA, Multivit

Current Illness: None

ID: 0962070
Sex: F
Age:
State: NY

Vax Date: 01/09/2021
Onset Date: 01/09/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Sore injection site; sore muscles; joint aches; Headache; Sore injection site, sore muscles, joint aches, headache, vomiting; This is a spontaneous report from a contactable other healthcare professional (HCP) (patient). A 33-year-old female patient received 1 dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via unspecified route on left arm, single dose for COVID-19 immunization on 09Jan2021, 12:45 PM, at 33-year-old. Medical history included: Crohn's, seasonal allergy. Known allergies reported as: tetracycline. The patient did not have COVID prior vaccination. Concomitant medication in two weeks included: budesonide; spironolactone; diphenhydramine hydrochloride (BENADRYL). No other vaccine received in four weeks. The patient had sore injection site, sore muscles, joint aches, headache, vomiting; all on 09Jan2021, 08:00 AM. No treatment received. The patient was not tested for COVID post vaccination. Action taken for BNT162B2 was not applicable. Outcome of the events was resolving. Information on the lot/batch number has been requested.

Other Meds: ; ; BENADRYL

Current Illness:

ID: 0962071
Sex: M
Age:
State:

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: diarrhea; brutal headache/ severe headache; This is a spontaneous report from a contactable consumer (patient parent). A 34-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via unspecified route single dose for COVID-19 immunization on 07Jan2021 at 34-year-old. Medical history and concomitant medication were not reported. After the first vaccine, the patient got a severe headache and diarrhea. It was reported that within a day (07Jan2021), he got a brutal headache, and the next day (08Jan2021) got diarrhea. Treatment received for diarrhea. Action taken for BNT162B2 was not applicable. Outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0962073
Sex: F
Age:
State: WA

Vax Date: 01/09/2021
Onset Date: 01/09/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Injection pain; headache; tiredness/feeling wornout; chills; body aches; chest tightness; This is a spontaneous report from a contactable consumer. A 48-year-old female patient received the second dose of the bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EL3249), via an unspecified route of administration in the left arm on 09Jan2021 at 09:00 at 48-years-old at a single dose for COVID-19 immunization. Medical history included Sulfonamide allergy, Factor V Leiden mutation, diabetes; all from an unknown date and unknown if ongoing. Concomitant medications included acetylsalicylic acid (BABY ASPIRIN), colecalciferol (VITAMIN D [COLECALCIFEROL]), lisinopril (MANUFACTURER UNKNOWN), vitamins nos (MULTIVITAMIN); all taken for an unspecified indication from an unspecified date to an unspecified date. The patient experienced the following events and outcomes: injection pain on 09Jan2021 20:00 with outcome of recovering , headache on 09Jan2021 20:00 with outcome of recovering, tiredness/feeling wornout on 09Jan2021 20:00 with outcome of unknown, chills on 09Jan2021 20:00 with outcome of recovering, body aches on 09Jan2021 20:00 with outcome of recovering, chest tightness on 09Jan2021 20:00 with outcome of recovering. The patient did not receive other vaccines in four weeks; there was no treatment for the adverse events; there was no prior COVID vaccination; there was no post vaccination COVID test.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021015284 same patient, different event and vaccine

Other Meds: BABY ASPIRIN; VITAMIN D [COLECALCIFEROL]; ; MULTIVITAMIN [VITAMINS NOS]

Current Illness:

ID: 0962074
Sex: F
Age:
State: OR

Vax Date: 01/06/2021
Onset Date: 01/07/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: having intermittent left-sided chest pain/The pain is worsened with deep breathing.; palpitations; This is a spontaneous report from a contactable Other Healthcare professional (HCP) (patient). A 30-year-old female patient (pregnant: No) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1283), via Intramuscular on left arm on 06Jan2021 at 14:00 at single dose for COVID-19 immunisation. The relevant medical history included known allergies: Penicillin and known allergies: Sulfa. Concomitant medications were reported as none. The patient previously took Ceclor and had known allergies. The day after receiving the first dose, on 07Jan2021 at 15:00 the patient had been having intermittent left sided chest pain. The pain was worsened with deep breathing. Additionally having palpitations. It had caused her enough concern that she went to the ED (Emergency room/department or urgent care). She had been encouraged to follow up in clinic. No other vaccine in four weeks. No other medications in two weeks. No Covid prior vaccination. No covid tested post vaccination. The outcome of the events was not recovered.

Other Meds:

Current Illness:

ID: 0962075
Sex: F
Age:
State: NJ

Vax Date: 01/09/2021
Onset Date: 01/10/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 20210107; Test Name: tested for COVID / Nasal Swab; Test Result: Negative ; Test Date: 20201216; Test Name: tested for COVID / saliva; Test Result: Negative

Allergies:

Symptoms: Headache; Tiredness; Sleepy; This is a spontaneous report from a contactable consumer (patient). A 44-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, via unspecified route on right arm single dose for COVID-19 immunization on 09Jan2021, 10:00 AM, at 44-year-old. Medical history included: allergies: dust. The patient did not have COVID prior vaccination. Concomitant medication was not reported. No other vaccine received in four weeks. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on left arm for COVID-19 immunization on 19Dec2020, 10:15 AM. On second day after the second dose of BNT162B2, on 10Jan2021, 08:00 AM, the patient had headache, tiredness, sleepy. No treatment received. The patient was tested for COVID, by saliva with negative result on 16Dec2020, by nasal swab with negative result on 07Jan2021. Action taken for BNT162B2 was not applicable. Outcome of the events was resolving.

Other Meds:

Current Illness:

ID: 0962076
Sex: F
Age:
State: MN

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 202011; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptoms: Alternating sweating and cold; Alternating sweating and cold; stomachache; Nausea; Fatigue; Headache; This is a spontaneous report from a non-contactable healthcare professional (reporting for herself). A 28-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular on 07Jan2021 10:45 in right arm at single dose for COVID-19 immunization. Medical history included hypothyroidism and major depression from an unknown date and unknown if ongoing. The patient had no allergies to medication, food, or other products. The patient had first dose of BNT162B2 on 18Dec2020 15:00 via intramuscular in left arm at single dose for COVID-19 immunization. Concomitant medications included levothyroxine, bupropion hydrochloride (WELLBUTRIN), "birth control" (not further specified, and escitalopram. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. On 08Jan2021, the patient experienced alternating sweating and cold, stomachache, nausea, fatigue, and headache at 1:00 AM. She was not hospitalized, and the events were reported as non-serious. Therapeutic measures taken as a result of the headache and included acetaminophen. The outcome of the events was resolving. The patient underwent lab tests and procedures which included nasal swab: negative in Nov2020. The facility where the most recent COVID-19 vaccine was administered was in the hospital. Since the vaccination, the patient has not been tested for COVID-19. The event was considered non serious as it did not result in death, was not life threatening, did not cause/prolonged hospitalization, was not disabling/Incapacitating and had no congenital anomaly/birth defect. No follow-up attempts are needed, information about lot/batch number cannot be obtained. Follow-up (14Jan2021): This is a follow-up report combining information from duplicate reports 2021013335 and 2021015838. The current and all subsequent information will be reported under manufacturer report number 2021015838. Additional information included: reaction data (alternating sweating and cold, stomachache, nausea, fatigue, and headache). No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ; ; WELLBUTRIN

Current Illness:

ID: 0962077
Sex: F
Age:
State: NY

Vax Date: 01/07/2021
Onset Date: 01/01/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 20210107; Test Name: Body temp; Result Unstructured Data: Test Result:99.6; Comments: I ran a fever starting at about 9 PM that evening of 99.6 which increased to 101.4; Test Date: 20210108; Test Name: Body temp; Result Unstructured Data: Test Result:101.4; Comments: I ran a fever starting at about 9 PM that evening of 99.6 which increased to 101.4; Test Date: 20210110; Test Name: Covid test; Result Unstructured Data: Test Result:Unknown result; Comments: Consumer stated, "No." (not clarified further)

Allergies:

Symptoms: Nasal congestion/congestion; Runny nose; I ran a fever starting at about 9 PM that evening of 99.6 which increased to 101.4; Arm pain from the injection site; Headache; Extreme fatigue; I just felt very tired; The initial case was missing the following minimum criteria: adverse event. Upon receipt of follow-up information on 11Jan2021, this case now contains all required information to be considered valid. This is a spontaneous report received from a contactable consumer (patient). A 50-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231, expiry date: Apr2021), via an unspecified route of administration in arm, on 07Jan2021, at single dose, for COVID-19 immunization. There were no medical history and concomitant medications. The patient stated, "I received the vaccination on Thursday of last week (07Jan2021) and I would say by 9 PM, of course I had the usual arm pain from the injection site, no big deal there. I had little bit of headache (07Jan2021) nothing serious. I had extreme fatigue, I just felt very tired when I went to work after that and then I ran a fever starting at about 9 PM that evening (07Jan2021) of 99.6 which increased to 101.4 by 1:00 in the morning (08Jan2021) and then Friday (08Jan2021), I started with some nasal congestion, runny nose, had congestion and that kind of things." The patient had COVID-19 test on 10Jan2021 and when probed about the results, she stated, "No" (Unknown results, pending clarification). Treatment for the events included Tylenol. The outcome of the events was unknown.

Other Meds:

Current Illness:

ID: 0962078
Sex: F
Age: 55
State: IL

Vax Date: 11/09/2020
Onset Date: 11/11/2020
Rec V Date: 01/21/2021
Hospital:

Lab Data: Ultrasound ordered -pending scheduling

Allergies: cloves, cranberries, prednisone

Symptoms: Patient contacted the office on 11/11/2020 reporting headache, muscle aches, tiredness, chills, and shivering. temperature of 99 degrees and right supraclavicular swelling. After 2 days, all of the symptoms except the right supraclavicular swelling had resolved. Patient was seen in the office 11/13/2020 and an area of right cystic fullness 5 x 4 cm was appreciated as well as a 2 cm lymph node. She was rechecked 12/17/2020. The lymph node was longer noted; the other swelling did not improve. On 1/17/2021, she reported no improvement and an ultrasound was ordered (pending).

Other Meds: Prevagen, Fexofenadine, gabapentin, metoprolol, paroxetine

Current Illness: hand pain, insomnia, HTN

ID: 0962079
Sex: F
Age:
State: CA

Vax Date: 01/09/2021
Onset Date: 01/09/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Malaise Myalgias arthralgias headache fever nausea from 12 hours post injection until 36 hours post injection; Malaise Myalgias arthralgias headache fever nausea from 12 hours post injection until 36 hours post injection; Malaise Myalgias arthralgias headache fever nausea from 12 hours post injection until 36 hours post injection; Malaise Myalgias arthralgias headache fever nausea from 12 hours post injection until 36 hours post injection; Malaise Myalgias arthralgias headache fever nausea from 12 hours post injection until 36 hours post injection; Malaise Myalgias arthralgias headache fever nausea from 12 hours post injection until 36 hours post injection; This is a spontaneous report from a contactable physician (patient). A 43-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: El1283), via an unspecified route of administration on 09Jan2021 06:30 at a single dose on right arm for COVID-19 immunization. Medical history included depression, obesity, penicillin and bee sting allergies. The patient was not pregnant at the time of vaccination. Patient was not diagnosed with COVID prior to vaccination. Concomitant medications included venlafaxine, cetirizine and ibuprofen. The patient previously took ceftriaxone sodium (ROCEPHIN) and experienced allergies. The patient was given first dose of bnt162b2 on 19Dec2020 18:30 on left arm for COVID-19 immunization (lot number: Eh9899). No other vaccines in four weeks prior to COVID vaccine. On 09Jan2021 18:00, the patient experienced malaise, myalgias, arthralgias, headache, fever and nausea from 12 hours post injection until 36 hours post injection. Treatment was given for the adverse events which included acetaminophen and ibuprofen. The patient has not been tested for COVID post vaccination. The patient was recovering from the events.

Other Meds: ; ;

Current Illness:

ID: 0962080
Sex: F
Age:
State: IL

Vax Date: 01/09/2021
Onset Date: 01/10/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Redness, swelling and itching at injection site; Redness, swelling and itching at injection site; Redness, swelling and itching at injection site; Redness, swelling and itching at injection site with joint pain going distally on arm; This is a spontaneous report from a contactable nurse (patient). A 43-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1283), intramuscular in left arm on 09Jan2021 10:30 at single dose for COVID-19 immunization. The patient's medical history was not reported. Concomitant medication included aspirin [acetylsalicylic acid], diphenhydramine hydrochloride (BENADRYL), ibuprofen and bifidobacterium bifidum, bifidobacterium lactis, bifidobacterium longum, lactobacillus acidophilus, lactobacillus rhamnosus (PROBIOTIC). The patient previously took cephalexin, ciprofloxacin, neomycin and macrobid [clarithromycin] and experienced drug allergies. The patient had first dose of BNT162B2 (lot number: EK5730) via intramuscular in left arm on 19Dec2020 10:15 AM at single dose. On 10Jan2021 08:00 AM, the patient experienced redness, swelling and itching at injection site with joint pain going distally on arm. No treatment received for the events. The facility where the most recent COVID-19 vaccine was administered was in the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was recovering.

Other Meds: ASPIRIN [ACETYLSALICYLIC ACID]; BENADRYL; ; PROBIOTIC [BIFIDOBACTERIUM BIFIDUM;BIFIDOBACTERIUM LACTIS;BIFIDOBACTERIUM LONGUM;LACTOBACILLUS ACIDO

Current Illness:

ID: 0962081
Sex: F
Age:
State: AR

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 20210109; Test Name: Temperature; Result Unstructured Data: Test Result:101-102; Test Date: 20210109; Test Name: Temperature; Result Unstructured Data: Test Result:99-100

Allergies:

Symptoms: Fever with chills (temperature varied from 101-102 and would decrease to 99-100); This is a spontaneous report from a contactable healthcare professional (patient). A 39-year-old female patient (non-pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL3246), via an unspecified route of administration in right arm, on 08Jan2021 at 17:00, at a single dose, for COVID-19 immunization. The patient's medical history included hypertension, glaucoma, Wolff-Parkinson-White syndrome (treated with ablation previously), and COVID-19 (prior vaccination). The patient's concomitant medications included amlodipine, metoprolol, colecalciferol (VIT D3), ascorbic acid (VIT C), and vitamin B complex (VITAMIN B). The patient previously took azithromycin (ZITHROMAX) and experienced allergies. No other vaccine was administered in four weeks. The facility where the vaccine was administered was a hospital. On 09Jan2021 (approximately 6 to 8 hours after the vaccine), the patient began running a fever with chills. The patient's temperature varied from 101-102 and would decrease to 99-100 with acetaminophen. The patient has not been tested for COVID-19 post-vaccination. The patient recovered from the event in Jan2021.

Other Meds: ; ; VIT D3; VIT C; VITAMIN B

Current Illness:

ID: 0962082
Sex: F
Age:
State: IA

Vax Date: 12/22/2020
Onset Date: 01/04/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Episcleritis; red, painful eye; red, painful eye; This is a spontaneous report from a contactable nurse (patient). A 56-years-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date unknown), intramuscular on the left arm on 22Dec2020 at 16:15 at a single dose for COVID-19 immunization. Medical history was not reported. Concomitant medications included propranolol (PROPRANOLOL), montelukast sodium (SINGULAIR), mometasone furoate (FLONASE [MOMETASONE FUROATE]) and multivitamin with minerals. The patient had no other vaccine in four weeks. The patient previously took and had known allergies with Morphine. The patient had no COVID-19 prior vaccination, had not tested post-vaccination. The patient developed red, painful eye on 04Jan2021 at 06:00 AM. The patient saw the eye doctor. Do with Episcleritis. It was also reported that the patient never had this thing before. The events resulted in healthcare professional office/clinic visit. Treatment for the events included Prednisolone eye drops. The events were resolving. Information on the lot/ batch number has been requested.

Other Meds: ; SINGULAIR; FLONASE [MOMETASONE FUROATE]

Current Illness:

ID: 0962083
Sex: F
Age:
State: MD

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: tingly lips; felt like throat was swelling; This is a spontaneous report from a contactable other hcp (patient). A 55-year-old non-pregnant female patient received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0142), via an unspecified route of administration in the left arm on 07Jan2021 14:30 at a single dose for COVID-19 immunization at the hospital. Medical history included high blood pressure and high cholesterol from an unknown date and unknown if ongoing. Concomitant medications included rosuvastatin, bupropion, and benazepril. The patient previously took amoxicillin;clavulanic acid (AUGMENTIN) and experienced allergies. The patient experienced tingly lips and felt like throat was swelling on 07Jan2021 16:30 with outcome of unknown. The events resulted in emergency room/department or urgent care. Treatments were Medrol dose pack and Prevacid. The patient was not diagnosed with COVID prior vaccination and had not tested for COVID post vaccination.

Other Meds: ; ;

Current Illness:

ID: 0962084
Sex: F
Age:
State: MI

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: If she saw a clear fluid run down the arm from the site of injection, did she actually get the full dose?; If she saw a clear fluid run down the arm from the site of injection, did she actually get the full dose?; If she saw a clear fluid run down the arm from the site of injection, did she actually get the full dose?; If she saw a clear fluid run down the arm from the site of injection, did she actually get the full dose?; This is a spontaneous report from a contactable consumer (patient) via Pfizer Sponsored Program. A female patient of an unspecified age started to receive first single dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number and exp date not reported), via an unspecified route of administration on 08Jan2021 for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got the first dose of COVID-19 vaccine on a Friday. After that, at home 2 hours later, she removed the band aid and a clear fluid ran down the arm from the site of injection. The patient was wondering if she actually got the full dose. Information on the lot/batch number has been requested. Follow-up (11Jan2021): New information from a contactable consumer via Pfizer Sponsored Program: includes report source. Vaccination site extravasation and discharge; and exposure via skin contact added as adverse events for the term " If she saw a clear fluid run down the arm from the site of injection, did she actually get the full dose." Information on the Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 0962085
Sex: M
Age:
State: CA

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Cough; muscle aches; joint pain; fatigue; headache; arm pain; This is a spontaneous report from a contactable physician (patient). A 38-year-old male patient received his second dose of BNT162B2 (lot number: EH2184), via an unspecified route of administration in the left arm on 07Jan2021 at 08:30 at single dose for Covid-19 immunization. Medical history was none. The patient had no known allergies. There were no concomitant medications. The patient received his first dose of BNT162B2 (lot number: EH9899) in the left arm on 17Dec2020 at 09:00 for Covid-19 immunization. The patient had no other vaccine in four weeks nor other medications in two weeks. The patient experienced cough requiring albuterol (the patient had never had any history of reactive airway disease or bronchoconstriction), other post-vaccine symptoms included muscle aches, joint pain, fatigue, headache, and arm pain; all on 08Jan2021 at 20:00. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient had no COVID prior vaccination nor tested with COVID post vaccination. The patient recovered from the events in Jan2021.

Other Meds:

Current Illness:

ID: 0962086
Sex: M
Age:
State: WI

Vax Date: 01/05/2021
Onset Date: 01/10/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 20210110; Test Name: Body temperature; Result Unstructured Data: Test Result:101.7; Test Date: 202101; Test Name: Body temperature; Result Unstructured Data: Test Result:100; Test Date: 20210110; Test Name: covid test (Nasal Swab)/Sars CoV-2 nucleic acid amplified test; Test Result: Negative

Allergies:

Symptoms: 2 bouts of diarrhea; bad heartburn; really bad headache; fever of 101.7/Fever of 100.0; chills; body aches; This is a spontaneous report from a contactable Other Health Professional (patient). A 31-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscularly in left arm on 05Jan2021 13:00 at single dose for COVID-19 immunization. Medical history was none (known allergies: No, other medical history: None). Concomitant medication in two weeks included escitalopram oxalate (LEXAPRO). The patient experienced really bad headache, fever of 101.7/fever of 100.0, chills, body aches, all on 10Jan2021 11:00 with outcome of recovering, 2 bouts of diarrhea and bad heartburn on 11Jan2021 with outcome of recovering. The patient underwent lab tests and procedures which included body temperature: 100 in Jan2021, 101.7 on 10Jan2021, Nasal Swab (Sars CoV-2 nucleic acid amplified test): negative on 10Jan2021. On 10Jan2021 11 am developed really bad headache, fever of 101.7, chills and body aches. On 11Jan2021 morning symptoms slowly improving with paracetamol (TYLENOL) but developed bad heartburn and 2 bouts of diarrhea. Fever of 100.0. No treatment received for heartburn and 2 bouts of diarrhea. AE resulted in: Doctor or other healthcare professional office/clinic visit. Facility type vaccine: Hospital. if other vaccine in four weeks: No. If treatment AE: No. If COVID prior vaccination: No. If COVID tested post vaccination: Yes. information on the Lot/Batch number has been requested.

Other Meds: LEXAPRO

Current Illness:

ID: 0962087
Sex: F
Age:
State: VA

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 20210108; Test Name: pulse; Result Unstructured Data: Test Result:101-129; Test Date: 20210108; Test Name: Tmax; Result Unstructured Data: Test Result:101.8; Test Date: 20210108; Test Name: O2 Sat; Result Unstructured Data: Test Result:95-98 %

Allergies:

Symptoms: itching across shoulders /back of neck; nausea; body aches; chills; She felt like there was a tight band around chest.; sense the she couldn't get a good breath; pulse of 101-129; she had tinnitus, and she noticed that both injections made that worse; This is a spontaneous report from a contactable nurse. A 63-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number EK4176/expiration date) dose number 2 intramuscularly on 08Jan2021 11:45 at a single dose on the left arm for COVID-19 immunization. The patient received the vaccine in a hospital. Medical history included severe allergic reaction to pecans and tinnitus. Historical vaccine included BNT162B2 on 18Dec2020 (dose number 1, intramuscularly on the left arm) for COVID-19 immunization. The patient experienced tinnitus, sinus infection, and stuffy head after the first dose. No other vaccines were administered within 4 weeks and no other medications were taken within 2 weeks. The patient was not diagnosed with COVID prior vaccination and was not tested for COVID post-vaccination. On 08Jan2021, after the 2nd dose, the patient experienced itching across shoulders/back of neck and sl nausea. She took Benadryl which relieved the itching. She went to bed and had onset of body aches, chills, and sense the she couldn't get a good breath. She felt like there was a tight band around chest. Her O2 Sat was 95% - 98%, with pulse of 101-129, T max was 101.8. The symptoms were lasting about 6 hours. In the morning, the patient took Aleve and Benadryl. Most symptoms were alleviated. She took those meds scheduled for 48 hrs. She noticed that if she tried to push past scheduled time, the itching started to return, so she just kept the meds scheduled for 48 hours. No other symptoms after that. She added that she had tinnitus, and she noticed that both injections made that worse. It was not yet subsiding since last injection. The patient also received Tylenol for the events. The outcome of the events was recovered in Jan2021.

Other Meds:

Current Illness:

ID: 0962088
Sex: F
Age:
State: GA

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: moderate tiredness; generalized achiness; mild chills/another episode of chills; Bad headache; severe nausea; Left arm pain-mild, less than flu shot pain; This is a spontaneous report from a contactable nurse (patient herself). A 56-year-old female patient received bnt162b2 (COVID 19, Pfizer, lot number: EL3246), via an unspecified route of administration on the left arm on 08Jan2021 16:45 at a single dose for an COVID-19 immunisation. Medical history included impaired gastroparesis, pancreatitis, hashimoto's thyroiditis, allergies: sulfa and adhesives. The patient's concomitant medications were not reported. The patient has known allergies with pethidine hydrochloride (DEMEROL). The patient is not pregnant. The patient has no COVID prior vaccination and was not COVID tested post vaccination. On 08Jan2021 at 19:45 (3 hours post vaccine), the patient experienced severe nausea that lasted for 29 hours; and left arm pain-mild, less than flu shot pain that lasted 3 days. At 22:45 (6 hours post vaccine), the patient had a bad headache that lasted 29 hours. On 09Jan2021 at 00:45 (8 hours post vaccine), the patient experienced mild chills that lasted 5 minutes, then 02:45 (10 hours post vaccine) another episode of chills that lasted 10 minutes. On 09Jan2021 at 04:45 (12 hours post vaccine), the patient experienced moderate tiredness and generalized achiness that lasted 24 hours. The patient recovered from severe nausea on 10Jan2021 00:45 and bad headache on 10Jan2021 03:45, recovered from left arm pain-mild, less than flu shot pain on 11Jan2021, recovered from chills on 09Jan2021 00:50, and recovered from moderate tiredness and generalized achiness on 10Jan2021 04:45.

Other Meds:

Current Illness:

ID: 0962089
Sex: M
Age:
State: PA

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: myalgias; fever; headache; nausea; This is a spontaneous report from a contactable consumer. A 32-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), via an unspecified route of administration (left arm) on 08Jan2021 (12:00 PM) at single dose for Covid-19 immunization. The patient's medical history reported as none; no known allergies. Concomitant medications were not reported. The patient previously received the first dose of BNT162B2 via an unspecified route of administration (left arm) on 18Dec2020. The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was reported that the day after the 2nd injection 09Jan2021, the patient had myalgias, fever, headache and nausea. It had mostly resolved on the following day 10Jan2021 and completely resolved on 11Jan2021. The patient took Tylenol and Advil as treatment. The outcome of events was recovered on 11Jan2021. The patient has not been tested for COVID-19 since the vaccination.

Other Meds:

Current Illness:

ID: 0962090
Sex: F
Age:
State: TN

Vax Date: 01/09/2021
Onset Date: 01/09/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Name: Temp; Result Unstructured Data: Test Result:At 12am was 101; Test Date: 20210110; Test Name: Temp; Result Unstructured Data: Test Result:At 10am; 102.7

Allergies:

Symptoms: At 10am feel hot, took temp was 102.7; At 10am feel hot, took temp was 102.7/ Temp at 12am was 101; Red all over; Face swelling; Shot site was red; Allergic reaction; Hives; Around 8pm start to feel chill; This is a spontaneous report from a contactable consumer. A 57-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number: el1284), via an unspecified route of administration on 09Jan2021 09:30 at SINGLE DOSE at right arm for COVID-19 immunization. Medical history included HTN, GERD, IBS, known allergies: PCN, IV contrast. Concomitant medications included lisinopril (LISINOPRIL), atorvastatin (ATORVASTATIN), linaclotide (LINZESS). The patient previously took morphine and percocet [oxycodone hydrochloride;paracetamol]; and experienced known allergies. The patient received first dose of bnt162b2 on 19Dec2020 09:30 at right arm. Lot number: el1284. The patient got the 2nd shot at 09:30, went back to work was fine, got home at 07:15pm, around 8pm on 09Jan2021 start to feel chill. On 09Jan2021 20:45, the patient was reported to be red all over, took 650 of Tylenol. Face swelling, the shot site was red. Went to bed at 9pm. Temp at 12am was 101. Went to the ER 12:50am. They stated the patient was having allergic reaction and hives (reported as 09Jan2021 20:45). The ER gave the patient Benadryl IV, Prednisone IV, Pepcid. They discharge the patient with Prednisone and Pepcid. On 10Jan2021 at 10am feel hot, on the same day took temp was 102.7. The patient had to miss work 1 day of work sunday 10Jan2021. The patient received treatment for the events. The patient visited the ER for the events. The outcome of the events was recovering.

Other Meds: ; ; LINZESS

Current Illness:

ID: 0962091
Sex: F
Age:
State: NY

Vax Date:
Onset Date: 01/01/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: Covid test; Test Result: Positive

Allergies:

Symptoms: I became aware that my sister was exposed to and tested positive for COVID (I assume at work as she is a nurse) after she had received the initial dose of the COVID-19 Pfizer vaccine; I became aware that my sister was exposed to and tested positive for COVID (I assume at work as she is a nurse) after she had received the initial dose of the COVID-19 Pfizer vaccine; This is a spontaneous report from a contactable consumer. A 32-year-old female patient received first single dose of BNT162B2 (Manufacturer: Pfizer, solution for injection, batch/lot number and exp date not reported), via an unspecified route of administration on an unspecified date for COVID -19 immunization. The patient's medical history and concomitant medications were not reported. Patient was not pregnant. Patient had no prior COVID vaccination. The reporter became aware that her sister was exposed to and tested positive for COVID (she assumed at work as she was a nurse) on Jan2021 after she had received the initial dose of the COVID-19 Pfizer vaccine. She was not sure when the exposure took place, but it had been about 3 weeks since she received the first dose. Patient was tested post vaccination. The outcome of events was recovering. No follow up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: The information currently provided is too limited to make a meaningful medical assessment hence, the events are conservatively assessed as related to the suspect drug BNT162B2 until further information becomes available.

Other Meds:

Current Illness:

ID: 0962092
Sex: F
Age:
State: MO

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: right eye right peripheral vision became starburst; This is a spontaneous report from non-contactable healthcare professional (patient). A 56-year-old female patient received the first dose of bnt162b2 (BNT162B2; lot number EL3248), intramuscular on the right arm on 07Jan2021 at 15:45 at a single dose in the hospital for covid-19 immunisation. Medical history included myasthenia gravis. The patient did not have COVID prior vaccination. The patient was not pregnant at the time of report. The patient received unspecified concomitant medications (other medications received in two weeks). On 08Jan2021 at 08:15 (also reported as approximately 18 hours post injection), the patient's right eye right peripheral vision became starburst. It was odd enough that patient thought it should be reported even if it might be coincidence. The patient did not receive treatment for the event. Vision resolved in about 45 minutes, on 08Jan2021 at 09:00. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0962093
Sex: F
Age:
State: NC

Vax Date: 01/08/2021
Onset Date: 01/01/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: approx 34 hours after vaccine awoke unable to breath. symptoms consistent with laryngospasm. symptoms lasted approx 2 minutes; approx 34 hours after vaccine awoke unable to breath. symptoms consistent with laryngospasm. symptoms lasted approx 2 minutes; This is a spontaneous report from a contactable other healthcare professional. A 44-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot ek9231) on 08Jan2021 03.00 pm intramuscular in the left arm for COVID-19 immunization. Medical history included RA, spondylitis, GERD, known allergies to sulfa, penicillin, cefalexin monohydrate (KEFLEX), sulfamethoxazole, trimethoprim (BACTRIM), adalimumab (HUMIRA), ankylosis. Concomitant medications included acetylsalicylic acid (ASPIRIN), omeprazole, loratadine (CLARITIN) and infliximab (RENFLEXIS). First dose of BNT162B2 was administered on 21Dec2020 11:00 am (lot ek5730) intramuscular in the left arm for COVID-19 immunization. Approx 34 hours after vaccine (also reported as 03Jan2021) awoke unable to breath. Symptoms consistent with laryngospasm, symptoms lasted approx 2 minutes. No treatment provided. No COVID test performed prior or after vaccination.; Sender's Comments: A possible causal association between administration of BNT162B2 and the onset of unable to breath/ Laryngospasm cannot be excluded, considering the plausible temporal relationship. Severe allergic reaction is the known risk for the product. The underlying predisposing condition of allergies to multiple materials may put the patient at high risk of allergic reaction to vaccine. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds: ASPIRIN [ACETYLSALICYLIC ACID]; ; CLARITIN [LORATADINE]; RENFLEXIS [INFLIXIMAB]

Current Illness:

ID: 0962094
Sex: M
Age:
State: CA

Vax Date: 12/28/2020
Onset Date: 01/06/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 202009; Test Name: Lab. work; Result Unstructured Data: Test Result:Unknown results; Test Date: 20210103; Test Name: covid 19; Test Result: Negative ; Comments: test on Sunday; Test Date: 20210104; Test Name: covid 19; Test Result: Negative ; Comments: negative on Monday; Test Date: 20210105; Test Name: covid 19; Test Result: Negative ; Comments: Tuesday different Company negative; Test Date: 20210106; Test Name: covid 19; Test Result: Positive ; Comments: he tested negative for the first four days after the vaccine, tested positive on 06Jan2021 and tested negative on 07Jan2021; Test Date: 20210107; Test Name: covid 19; Test Result: Negative ; Comments: he tested negative for the first four days after the vaccine, tested positive on 06Jan2021 and tested negative on 07Jan2021

Allergies:

Symptoms: tested positive on 06Jan2021/Came positive for COVID; I am concerned because I am positive; tested positive on 06Jan2021/Came positive for COVID; I am concerned because I am positive; This is a spontaneous report from a contactable consumer. A 61-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899, expiry date Mar2021), via an unspecified route of administration on 28Dec2020 at a single dose for covid-19 immunization. Medical history included diabetes. There were no concomitant medications. The patient got the vaccination on 28Dec2020. He have been testing every day. The patient got a tested on Sunday, 03Jan2021 and was negative. He was negative on Monday, 04Jan2021 different Company. He went back on Tuesday, 05Jan2021, different Company and was negative. On Wednesday, 06Jan2021, he was tested positive, then on Thursday, 07Jan2021, he was tested negative. He wanted to know if he can continue to get the second vaccination shot 18Jan2021 or not?. The patient did not received any treatment for the event and he just stayed at home. The patient had a lab work last Sep2020. The outcome of the events was unknown.

Other Meds:

Current Illness:

ID: 0962095
Sex: M
Age:
State: CA

Vax Date: 12/22/2020
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Name: COVID-19; Test Result: Positive

Allergies:

Symptoms: contracted COVID after the first dose; contracted COVID after the first dose; This is a spontaneous report from a contactable nurse (patient). A 36-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 22Dec2020 at a single dose for COVID-19 vaccine. Medical history and concomitant medications were not reported. It was reported that the patient contracted COVID after the first dose on an unspecified date. He has question about the second dose. He had his first dose on 22Dec2020. He contracted COVID in-between doses. His second dose was due today. He wanted to know if he should receive it today or what was the safety issue. He asked if was it safe to get the second dose of his COVID vaccine if he had COVID? Lab data included COVID-19 positive on an unspecified date. The outcome of 'contracted COVID after the first dose' was unknown. Information on the lot/ batch number has been requested.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation. However, full immunity is only expected 2 weeks after the second dose.

Other Meds:

Current Illness:

ID: 0962096
Sex: F
Age:
State: CA

Vax Date: 12/29/2020
Onset Date: 01/07/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: scabies; itching; rash neck to waist down/she developed a rash on her back; This is a spontaneous report from a contactable consumer (patient). A 93-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot/batch number unknown), via an unspecified route of administration on 29Dec2020 at a single dose for COVID-19 immunization. Medical history included pacemaker. The patient's concomitant medications were not reported. She received the COVID vaccine on 29Dec2020 and 10 days later she developed a rash neck to waist down, she is in the nursing home and they are not sure if its scabies, she said the itching has lessened. She is in the nursing home for follow up for her pacemaker. caller wanted to know if there are reports of rash. Patient wanted to know about partial immunity (immunity after the first dose) and how long it takes to build it. Reporter wanted to find out if anyone reported a skin rash after having the Covid shot. Stated that her rash started 10 days later on her back and it looked like scabies. Stated that it will be treated as scabies. Stated the she did a report about the above mentioned previously. Stated that she is going to see her doctor later on today. It was also reported that she had the COVID vaccine 29Dec2020 and 10 days later on 07Jan2021, she developed a rash on her back and she was wondering if this was normal. It was confirmed that the patient was given the Pfizer BioNtech COVID-19 vaccine on 29Dec2020 and then developed a rash on her back 07Jan2021. She was asking if this was from the shot? Is the rash something that has been reported before? How long until she has some sort of immunity after getting first vaccine? She was not sure it is a side effect for sure. The aid at the nursing home thought it was scabies. But the patient has not been in contact with anyone with scabies, and has a clean bed and everything. The outcome of the event 'itching' was recovering while unknown for the other events. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0962097
Sex: F
Age:
State: WA

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Name: temperature; Result Unstructured Data: Test Result:102.3

Allergies:

Symptoms: severe muscle pain; joint pain; temperature 102.3; headache; nausea; fatigue; generalized body aches; diarrhea; This is a spontaneous report from a contactable physician (patient). A 55-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1283), via an unspecified route of administration (left arm) on 07Jan2021 (17:45) at single dose for Covid-19 immunization. The patient previously received the first dose of BNT162B2 (lot number: EL1283) on 19Dec2020 (01:15 PM) via an unspecified route (left arm). Medical history included asthma and "known allergies: yes". Concomitant medications included fish oil (OMEGA 3), colecalciferol (VITAMIN D), ascorbic acid (VITAMIN C), and meloxicam. The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced severe muscle pain, joint pain (fingers, skin!-pending clarification), temperature 102.3, headache, nausea lasting 24hours, followed by persistent fatigue and generalized body aches and diarrhea for the next 24hours. The patient was treated with acetaminophen. The outcome of events was recovering. The patient has not been tested for COVID-19 since the vaccination.

Other Meds: OMEGA 3 [FISH OIL]; VITAMIN D [COLECALCIFEROL]; VITAMIN C [ASCORBIC ACID];

Current Illness:

ID: 0962099
Sex: M
Age:
State:

Vax Date: 01/05/2021
Onset Date: 01/01/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Pain at the injection site; Swelling in his lymph nodes; Fatigue; This is a spontaneous report from a contactable consumer. A male patient (reporter's father) of an unspecified age (Age: 65; Unit: unknown) received single dose of BNT162B2 (Solution for injection, batch/lot number and exp date not reported), via an unspecified route of administration on 05Jan2021 for COVID -19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the Covid-19 vaccine last Tuesday. On 06Jan2021, the day after the injection, he developed pain at the injection site that quickly resolved, and he felt great. He recently developed swelling in his lymph nodes and fatigue and the caller would like to know if that is normal to have this delayed reaction 5-6 days later. The patient recovered from the pain at the injection site on an unspecified date in Jan2021. Outcome of other events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0962100
Sex: M
Age: 23
State:

Vax Date: 01/06/2021
Onset Date: 01/07/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Event: Fever (100.4), chills, nausea, headache Treatment: Rest, Tylenol & Advil Outcomes: Better within 24 hours

Other Meds:

Current Illness:

ID: 0962101
Sex: F
Age:
State: FL

Vax Date: 01/07/2021
Onset Date: 01/01/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Name: fever; Result Unstructured Data: Test Result:101; Test Name: fever; Result Unstructured Data: Test Result:102; Test Name: COVID; Result Unstructured Data: Test Result:negative

Allergies:

Symptoms: did not feel like herself; fever; shaking; chills; tiredness; arm swelling; headache; This is a spontaneous report from a contactable consumer (patient). This consumer reported similar events for 17 patients. This is the first of seventeen reports. A female patient of an unspecified age started to receive bnt162b2 (BNT162B2), via an unspecified route of administration on 07Jan2021, single for COVID-19 immunization. Medical history included covid-19. The patient's concomitant medications were not reported. The patient reported that after getting the vaccine she experienced a fever up to 102, chills and shaking on Jan2021. She also reported that multiple friends had the "regular side effects" of soreness in the arm. Patient stated that she got her COVID vaccine shot on along with 15 of her friends. They all had the typical arm swelling, headache, and tiredness if anything. Some did not have any side effects at all. She herself woke up with a 101 fever, then at 11 AM had a 102 fever and was shaking like crazy she could not even hold the thermometer in her mouth on 07Jan2021. On 08Jan2021, (Friday), she began to feel a little better. She just did not feel like herself on 09Jan2021. She got a COVID swab and was negative. After she got the fever she decided to have her blood drawn, and it showed antibodies. Patient was inquiring, because she previously had COVID, is that why she had this reaction. Outcome of the event swas unknown. Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : PFIZER INC-2021021735 same reporter/ drug/ events, different patient;PFIZER INC-2021026894 same reporter/drug/event, different patient;PFIZER INC-2021026885 same reporter/drug/event, different patient PFIZER INC-2021026883 same reporter/drug/AE, different patient PFIZER INC-2021026893 same reporter/drug/similar event, different patient;PFIZER INC-2021026888 Same reporter/drug/event, different patient;PFIZER INC-2021026890 same reporter/drug/event, different patient;PFIZER INC-2021026886 same reporter/product, diff AE/patients;PFIZER INC-2021026413 same reporter/drug/event, different patient;PFIZER INC-2021026881 same reporter/drug/event, different patient;PFIZER INC-2021026882 same reporter/drug/event, different patient;PFIZER INC-2021026884 same reporter/drug/event, different patient;PFIZER INC-2021026889 same reporter/drug/event, different patient;PFIZER INC-2021026891 same reporter/drug/event, different patient;-PFIZER INC-2021026892 same reporter/drug/event, different patient

Other Meds:

Current Illness:

ID: 0962102
Sex: F
Age:
State: FL

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Injection into left arm hurt upon injection; The arm got very sore and felt like lead-I could barely raise my arm up without assistance of the other arm; The arm got very sore and felt like lead-I could barely raise my arm up without assistance of the other arm; This is a spontaneous report from a contactable consumer (patient). A 69-year-old female patient received the first dose of BNT162B2 (Pfizer-BIONTECH Covid-19 Vaccine), via an unspecified route of administration in the left arm on 07Jan2021 at 14:00 at a single dose for COVID-19 immunisation. Medical history included HBP (hypertension). The patient was not pregnant at the time of vaccination, has not received any other vaccine within four weeks, and did not have COVID prior to the vaccination. Concomitant medication included losartan (also reported as other medication in two weeks). The patient previously took Aleve and experienced allergies. On 07Jan2021 at 02:00 PM, the patient experienced injection into left arm hurt upon injection and as the hours wore on, the arm got very sore and felt like lead-she could barely raise her arm up without assistance of the other arm. However, it dissipated within 24 hours and felt fine thereafter. The patient did not test positive for COVID post-vaccination. The patient did not receive any treatment for the events. Outcome of the events was recovered on an unspecified date. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0962103
Sex: F
Age:
State: MD

Vax Date: 01/09/2021
Onset Date: 01/09/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Diffuse rash and left supraclavicular lymphadenopathy; Diffuse rash and left supraclavicular lymphadenopathy; This is a spontaneous report from a contactable other health professional (patient). A 41-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot:EL0142) via an unspecified route of administration into the left arm on 09Jan2021 08:45 at a single dose for covid-19 immunisation. Medical history was reported as non. The patient's concomitant medications were not reported. The patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot:ES1685) via an unspecified route of administration into the left arm on 19Dec2020 08:45 at a single dose for covid-19 immunization. On 09Jan2021 20:00, it was reported that the patient experienced diffuse rash and left supraclavicular lymphadenopathy. It was also reported that the events reported was treated with loratadine (CLARITIN). Patient was not pregnant. Outcome of events was not recovered.

Other Meds:

Current Illness:

ID: 0962104
Sex: F
Age:
State: NJ

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Fatigue; Headache; chills; muscle aches; This is a spontaneous report from a contactable healthcare professional (patient). A 43-year-old non-pregnant female patient received her second dose of bnt162b2 (BNT162B2 reported as Pfizer COVID-19 vaccine; lot number: EK9231), via an unspecified route of administration left arm on 08Jan2021 08:00 at a single dose for covid-19 immunization. Medical history included asthma, high blood pressure, hypothyroid, insulin resistance and allergies to sulpha. Concomitant medication included liraglutide (VICTOZA), metformin (METFORMIN), levothyroxine sodium (SYNTHROID), losartan potassium (COZAAR). The patient previously took enalapril but had allergies. The patient received her vaccine in a hospital. The patient received his first dose of bnt162b2 (BNT162B2 reported as Pfizer COVID-19 vaccine; lot number: EH9899), via an unspecified route of administration left arm on 08Jan2021 08:00 at a single dose for covid-19 immunization. The patient experienced fatigue, headache, chills and muscle aches on 08Jan2021 02:00 PM (14:00). No treatment was received for the adverse events. The patient was not diagnosed with Covid-19 prior vaccination and has not been tested for Covid-19 post vaccination. The outcome of the events was recovered on Jan2021. No follow-up attempts are possible. No further information is expected.

Other Meds: VICTOZA; ; SYNTHROID; COZAAR

Current Illness:

ID: 0962105
Sex: F
Age:
State: AL

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: She was observed scratching and when questioned stated she was itchy on her chest and forearms; This is a spontaneous report from a contactable pharmacist. A 64-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1283) intramuscularly at right arm on 11Jan2021 08:45 at single dose for COVID-19 immunization. Medical history included seasonal allergies. The patient's concomitant medications were not reported. The patient previously received the first dose of bnt162b2 (lot number: EK5730) intramuscularly on 21Dec2020 at single dose for COVID-19 immunization. Patient received vaccine at 08:45, she was observed for 30 minutes - during which time she took 50mg diphenhydramine hydrochloride (Benadryl) (patient's own med) - she was observed scratching and when questioned stated she was itchy on her chest and forearms. She denied any difficulty breathing, swelling around face, lips, tongue or itchiness anywhere other than her chest and forearms. She was observed for minutes after diphenhydramine hydrochloride and all symptoms had resolved. Patient was instructed to read Fact sheet and report additional allergic symptoms and to follow up if any symptoms worsen. No other vaccine in four weeks. No covid prior vaccination. No covid tested post vaccination. The outcome of the event was recovered on 11Jan2021.

Other Meds:

Current Illness:

ID: 0962106
Sex: F
Age:
State: TX

Vax Date: 01/09/2021
Onset Date: 01/09/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 20210109; Test Name: fever; Result Unstructured Data: Test Result:101.7; Comments: within 30 mins

Allergies:

Symptoms: body pain; rapid onset of fever (within 30 min 101.7); skin sensitivity; cough; itchy throat; violent episodes of shaking and chills for 36 hours; violent episodes of shaking and chills for 36 hours; increased urination/diuresis; This is a spontaneous report received from a contactable nurse (who is also the patient). A 44-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), intramuscular in left arm, on 09Jan2021 07:30, at single dose, for COVID-19 immunization, in the hospital. The patient medical history was not reported. The patient is not pregnant. The patient had no other medications in two weeks. The patient did not have COVID-19 prior to vaccination. Historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), intramuscular in right arm, on 22Dec2020 12:00, at single dose, for COVID-19 immunization. The patient experienced body pain, rapid onset of fever (within 30 min. 101.7, as reported), skin sensitivity, cough, itchy throat, violent episodes of shaking and chills for 36 hours and increased urination/diuresis all on 09Jan2021 at 22:15. No treatment was received for the events. The patient was not tested for COVID-19 post vaccination. The outcome of the events body pain, rapid onset of fever (within 30 min 101.7), skin sensitivity, cough, itchy throat and increased urination/diuresis was recovered on unspecified dates; and the outcome of violent episodes of shaking and chills for 36 hours was recovered on 11Jan2021 at 08:15. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0962107
Sex: F
Age:
State: MA

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 20201229; Test Name: Covid test (Nasal Swab); Test Result: Negative

Allergies:

Symptoms: swollen lymph nodes on left side of neck; first dose on 27Dec2020 and second dose on 07Jan2021; This is a spontaneous report from a contactable nurse (patient herself). A 63-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection; batch/lot number and expiration date were unknown), via an unspecified route of administration on the left arm on 07Jan2021 at a single dose for COVID-19 immunization. The patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection; batch/lot number and expiration date were unknown), via an unspecified route of administration on the left arm on 27Dec2020 at 16:45. Both doses were administered at the hospital. Relevant medical history included non-insulin-dependent diabetes mellitus (NIDDM), hypertension (HTN), hypersensitivity lung disease (HLD), hyperthyroid, and Graves. The patient had no known allergies. Concomitant medications included empagliflozin (JARDIANCE), metformin, methimazole, cetirizine hydrochloride (ZYRTEC), and montelukast sodium (SINGULA). The patient was not pregnant. The patient had no other vaccine in four weeks. The patient had no Covid prior vaccination. The patient received her first dose on 27Dec2020 and second dose on 07Jan2021. The patient had an adverse event on the next eve of the second (2nd) vaccine. On 08Jan2021 at 22:00, she experienced swollen lymph nodes on left side of neck. The swelling was going down incrementally as she took paracetamol (TYLENOL) 1000 mg per oral (p.o.) daily. The patient underwent Covid test via nasal swab post vaccination on 29Dec2020, which resulted negative. The patient was recovering from the event. Information on the batch/lot number has been requested.

Other Meds: JARDIANCE; ; METHIMAZOLE; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; SINGULA

Current Illness:

ID: 0962108
Sex: F
Age:
State:

Vax Date: 01/07/2021
Onset Date: 01/01/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: muscle aches and joint paint; Result Unstructured Data: Test Result:5-7

Allergies:

Symptoms: headache; fatigue; muscle aches; joint pain; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age (reported as Age: 59; Unit: Unknown) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not provided), via an unspecified route of administration on 07Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced headache, fatigue, muscle aches, and joint pain on an unspecified date in Jan2021. The patient was still experiencing muscle aches and joint pains 5-7 out of 10 currently. She reached out to healthcare professional and vaccination clinic which referred her to Pfizer. She was wondering if it was okay to be experiencing side effects that long. The outcome of the events muscle aches and joint pain was not recovered while the outcome of the events headache and fatigue was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0962109
Sex: F
Age:
State: TX

Vax Date:
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Name: glucose levels; Result Unstructured Data: Test Result:doing something as far; Comments: if the vaccine is doing something as far as my glucose levels or just doing something else that's causing me to have headache

Allergies:

Symptoms: headache; nausea; feeling unwell; fatigue; fell in asleep; glucose levels or just doing something else that's causing me to have headache; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number: EL324U), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received first dose of vaccine, and since yesterday the patient have had headache that does not go away with like Ibuprofen and Tylenol. When the patient first got it she was reading on the factsheet that headache, nausea and feeling unwell are some of the symptoms so the patient was getting those and have had some fatigue as well but then she fell in asleep. And this morning, the patient have a headache that goes and come, it's not really, really bad but it's just like it is there and it just bothers her. It was reported that "I was taking Tylenol and Ibuprofen and it really doesn't seem to do anything. I noticed that if I eat something then I will start feeling a little bit better so, I do not know if the vaccine is doing something as far as my glucose levels or just doing something else that's causing me to have headache." The patient received treatment for the events. The outcome of the events was unknown.

Other Meds:

Current Illness:

ID: 0962111
Sex: F
Age:
State: NY

Vax Date: 01/07/2021
Onset Date: 01/09/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 20210104; Test Name: PCR; Test Result: Negative ; Test Date: 20210104; Test Name: Nasal Swab; Test Result: Negative ; Comments: covid test name post vaccination PCR

Allergies:

Symptoms: I had severe nerve pain in the arm I received the injection in/the pain is intermittent and severe and starts from upper arm to my fingers; This is a spontaneous report from a contactable nurse. A 45-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number: EL0142), via an unspecified route of administration on 07Jan2021 10:30 at single dose at left arm for COVID-19 immunization. Medical history included seizure, meningioma, and asthma. Known allergies: Latex, reglan, and Bactrim. Concomitant medications included lamotrigine (LAMICTAL), mirabegron (MYRBETRIQ). The patient previously took reglan [metoclopramide], and bactrim and experienced allergies. On day 2, 09Jan2021 21:00 post vaccine the patient reported "I had severe nerve pain in the arm I received the injection in. the pain is intermittent and severe and starts from upper arm to my fingers." It was unknown if the patient received treatment for the event. The patient underwent lab tests and procedures which included Nasal Swab: negative, and PCR: negative covid test name post vaccination PCR; both on 04Jan2021. The outcome of the event was not recovered.

Other Meds: LAMICTAL; MYRBETRIQ

Current Illness:

ID: 0962112
Sex: F
Age:
State: FL

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Strong chills; Bad headache; Very painful abdominal cramping; Heavy salivating; Nausea/going to vomit; Both hands went numb with pins and needles; Both hands went numb with pins and needles; This is a spontaneous report from a contactable consumer. A 70-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number: EL1284), via an unspecified route of administration from 08Jan2021 09:00 at SINGLE DOSE at right arm for COVID-19 immunization. Medical history included known allergies: latex, high blood pressure, hypothyroidism, and mitral valve prolapse. There were no concomitant medications. At 11am, 2 hours after receiving the first COVID19 vaccine, my reactions occurred simultaneously. The patient experienced Strong chills, Bad headache, Abdominal Very painful abdominal cramping, Heavy salivating, Nausea, Both hands went numb with pins and needles, the patient felt like she was either going to vomit or have a bowel movement, ultimately it was the latter. This is when both her hands went numb. These reactions lasted 15-20 minutes and then dissipated with the exception of a lingering less painful headache through Friday and Saturday. The patient did not receive treatment for the events. The outcome of the events was recovered.

Other Meds:

Current Illness:

ID: 0962113
Sex: F
Age:
State: KY

Vax Date: 01/06/2021
Onset Date: 01/10/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 20210111; Test Name: Nasal Swab/ PCR; Result Unstructured Data: Test Result:Unknown results

Allergies:

Symptoms: Inability to taste or smell; Inability to taste or smell; This is a spontaneous report from a contactable nurse. A 25-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number EK5730/expiration date) dose number 1, intramuscularly on 06Jan2021 12:00 at a single dose on the left arm for COVID-19 immunization. There was no relevant medical history. Concomitant medications were not reported. No other vaccine was received within 4 weeks and no other medications were taken within 2 weeks. The patient experienced inability to taste or smell on 10Jan2021. The patient underwent Nasal Swab/PCR on 11Jan2021 with unknown results (pending). The outcome of the events was not recovered.

Other Meds:

Current Illness:

ID: 0962114
Sex: M
Age:
State: NV

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Chills; fever; body and muscle aches; body and muscle aches; fatigue; This is a spontaneous report from a contactable nurse (patient). A 47-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 08Jan2021 16:45 (04:45 PM) at a single dose for COVID vaccine. There was no medical history. The patient had no known allergies. Concomitant medications were not reported. The patient previously had his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date at a single dose for COVID vaccine. He had no other vaccine in four weeks. The patient experienced chills, fever, body and muscle aches, fatigue, all on 09Jan2021 08: 00 AM. Treatment was not received for the events. The patient had no COVID prior to vaccination and did not have COVID tested post vaccination. The outcome of the events was recovering. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0962115
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: She referred to herself as a "long-hauler" still experiencing symptoms of muscle pain, tightness; She referred to herself as a "long-hauler" still experiencing symptoms of muscle pain, tightness; This is a spontaneous report from a contactable other healthcare professional (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiration date were unknown), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. Medical history included asthma and history of SARS-COV-2 from 2020, reported as 6 months ago. The patient is taking breathing treatments (unspecified). The patient referred to herself as a "long-hauler" still experiencing symptoms of muscle pain, tightness on an unspecified date. The patient has not recovered from the events. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0962116
Sex: M
Age:
State: PA

Vax Date: 12/30/2020
Onset Date: 01/05/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Developed apthous ulcers in throat 6 days after vaccine; This is a spontaneous report from a contactable physician (patient). A 55-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: EK7350), via an unspecified route of administration in left arm on 30Dec2020 18:00 at a single dose for COVID-19 immunization in a hospital. The patient's medical history was not reported. Concomitant medication included multivitamin. The patient previously took LEVAQUIN and experienced allergies. The patient developed aphthous ulcers in throat on 05Jan2021 14:00 6 days after vaccine. Patient does not have COVID prior vaccination. The patient has not been tested for COVID post vaccination. Treatment for the event included magic mouthwash, Vitamin C, and one dose of oral Medrol. The outcome of the event was recovering.

Other Meds:

Current Illness:

ID: 0962117
Sex: F
Age:
State:

Vax Date: 12/22/2020
Onset Date: 12/28/2020
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 20201229; Test Name: Nasal Swab test; Test Result: Positive

Allergies:

Symptoms: COVID-19; COVID-19; This is a spontaneous report from a contactable pharmacist (reporting for herself). A 36-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: EK5730), via an unspecified route of administration in the left arm on 22Dec2020 at a single dose for COVID-19 immunization. There was no medical history and no concomitant medications. The patient experienced COVID-19 on 28Dec2020, which was reported as being medically significant. The patient underwent lab tests and procedures which included nasal swab test: positive on 29Dec2020. Therapeutic measures were taken as a result of the event and included treatment with bamlanivimab on 30Dec2020. The outcome of COVID-19 was recovered on 07Jan2021. The causality was reported as no (unrelated); Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors; however, a contributory role of the suspect product BNT162B2 to the reported drug ineffective and COVID-19 cannot be ruled out.

Other Meds:

Current Illness:

ID: 0962118
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Pain in the arm; Swelling in her lymph nodes; This is a spontaneous report from a Pfizer-sponsored program. A contactable physician (patient's colleague) reported that a female patient of an unspecified age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number and Expiration Date were not reported), via an unspecified route of administration in arm, on an unspecified date, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took the first dose of BNT162B2 for COVID-19 immunization (in arm). On an unspecified date, the patient received the second dose of the COVID-19 vaccine in the same arm as the first dose and was experiencing pain in the arm and swelling in her lymph nodes (after the second dose administration). The physician would like to know if there is any information on whether or not the second dose should be given in the opposite arm of the first dose. The outcome of the events was unknown. Information about lot number and expiration date for the suspect product will be requested in follow-up attempts.

Other Meds:

Current Illness:

ID: 0962119
Sex: F
Age:
State: FL

Vax Date:
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: facial numbness that started on her cheek, nose, and neck; This is a spontaneous report from a contactable pharmacist. A 44-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (pending clarification) at single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that within 10 minutes of administration, the patient experienced facial numbness that started on her cheek, nose, and neck. Three weeks later, she still has the numbness. The patient has reported improvement, but it has not been totally resolved. The patient described it as receiving a shot of Novocaine from the dentist but does not describe the sensation of paralysis or bell's palsy. The reporter asked whether or not the patient should receive the second dose of the vaccine after experiencing this side effect. Her 3-week mark was on Friday, in which she has missed her second dose (pending clarification). The patient received an unspecified treatment for the event. The outcome of event was recovering. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0962120
Sex: F
Age:
State: NY

Vax Date: 01/08/2021
Onset Date: 01/01/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Name: heart; Result Unstructured Data: Test Result:normal; Comments: normal and clear and my vitals were normal.; Test Name: lungs; Result Unstructured Data: Test Result:normal and clear; Comments: normal and clear and my vitals were normal.

Allergies:

Symptoms: joint pain; tiredness; headache; muscle pain in my joints; musculoskeletal pain; I felt a little bit feverish and warm/I had a slight fever; a slight heaviness on my chest; needed to take a nap, more than normal; really not feeling well; feeling very achy; This is a spontaneous report from a contactable nurse (patient). A female patient of an unspecified age (reported as '30', unknown unit), received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), via an unspecified route of administration on 08Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient had her shot on Friday morning (08Jan2021) and felt no pain at all, at the injection site, it didn't hurt at all in my left deltoid muscle. She felt great afterwards after the whole day. Then about the 2nd-3rd day on after she felt she had a little bit of joint pain on Jan2021. On the 3rd day patient felt a little bit of tiredness, headache, muscle pain in my joints as well musculoskeletal pain. She felt a little bit feverish and warm. She normally run 97 and I'm usually cold, but I was definitely a lot warmer and a slight heaviness on my chest on the 4th day feeling she needed to take a nap, more than normal. She have a stethoscope, heard her lungs and heart which was normal and clear and vitals were normal. She wasn't having a reaction or anything. Patient took Tylenol and Ibuprofen as well and that helped. Patient was fine. It only lasted about 4-5 hours that she was really not feeling well and needed to sleep and take a nap. She was just feeling very achy and headachy and body achy and after she woke up and had a slight fever, sweating if off and then felt fine. She had no other symptoms and her arm felt fine where she got the injection site. All events happened on Jan2021. Outcome of the events was recovered on an unspecified date in Jan2021. Information about Lot/Batch has been requested.

Other Meds:

Current Illness:

ID: 0962121
Sex: F
Age:
State:

Vax Date: 01/09/2021
Onset Date: 01/09/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 20210110; Test Name: fever; Result Unstructured Data: Test Result:up to 101; Test Date: 20201114; Test Name: Nasal Swab (COVID test); Test Result: Negative

Allergies:

Symptoms: Fever up to 101; severe body aches; severe chills; nausea; fatigue; headache; BNT162B2 1st dose: 23Dec2020/BNT162B2 2nd dose: 09Jan2021 14:45; This is a spontaneous report from a non-contactable nurse reported that a 25-year-old female patient received second dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: EK9231; expiry date: not known) on 09Jan2021 14:45 and first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: EK5730; expiry date: not known) on 23Dec2020, both intramuscular in the right arm at single dose for COVID-19 immunization, administered in hospital. The patient's medical history was not reported. Concomitant medication included ethinylestradiol, norgestrel (CRYSELLE) (medication received in two weeks). The patient had no COVID prior to vaccination. The patient experienced fever up to 101, severe body aches, severe chills, nausea, fatigue, and headache on 10Jan2021. No treatment was received for these reported events. The patient underwent lab tests and procedures which included nasal swab (COVID test) on 14Nov2020: negative. The outcome of the events fever up to 101, severe body aches, severe chills, nausea, fatigue, and headache was recovering. No follow-up attempts are possible. Information on lot/batch number cannot be obtained. No further information is expected.

Other Meds: CRYSELLE

Current Illness:

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm